期刊
EMERGING INFECTIOUS DISEASES
卷 26, 期 4, 页码 793-795出版社
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2604.181655
关键词
-
资金
- NIH/FIC [R21TWO10202]
- DOD/AFOSR [FA9550-16-1-0479]
We developed a carbapenemase test based on the ability of imipenem to inhibit noncarbapenemase beta-lactamases. The test uses bacterial isolates with a fluorescent beta-lactamase substrate, producing objective results with 100% sensitivity and specificity in 10 minutes. The assay is inexpensive and consists of only 1 mixing step.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据